Metsera plunges as bidding war ends with Pfizer securing $10 billion deal
Metsera bid exit gives boost to Novo Nordisk shares
Novo Nordisk shares rise after dropping Metsera bid
The Week in Breakingviews: Doing battle over drugs
Newscasts - Pfizer wins $10 billion Metsera bidding war as Novo Nordisk exits
Brief: Novo Nordisk Says Will Not Increase Its Proposal To Acquire Metsera, Inc.
Brief: Metsera Says Pfizer to Buy Metsera For Up To $86.25 Per Share
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports (updated)
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
Brief: Pfizer Sweetens Its Offer For Metsera In Bidding War Against Novo - Bloomberg News
Press Digest: Financial Times - November 7
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm
Factbox: What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?
Metsera jumps on reports of Novo Nordisk's sweetened bid
Brief: Novo Nordisk Again Raises Bid In Takeover Fight For Metsera - FT
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle (updated)
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle
Novo Nordisk has edge in US obesity bun fight
Novo, Lilly shares rise as Trump obesity drug deal nears